STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $7,267,000 | -16.8% | 495,384 | +15.5% | 0.01% | -12.5% |
| Q1 2014 | $8,736,000 | +17.4% | 429,078 | +13.0% | 0.01% | +14.3% |
| Q4 2013 | $7,443,000 | -58.6% | 379,741 | -4.3% | 0.01% | -61.1% |
| Q3 2013 | $17,963,000 | +154.0% | 396,619 | +33.7% | 0.02% | +157.1% |
| Q2 2013 | $7,073,000 | – | 296,693 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |